News
Stay up to date with PredictImmune
Latest News
PredictImmune Ltd appoints Aarti Gurnani as Chief Executive Officer
Aarti joins PredictImmune after 25 years in leadership and commercial roles in the technology sector. Having initially trained as an attorney in the US, she transitioned to industry…
PredictImmune establishes IBD Clinical Advisory Board to advise on European access to PredictSURE® IBD
PredictImmune establishes IBD Clinical Advisory Board to advise on European access to PredictSURE® IBDCambridge, UK, 02 February: PredictImmune,...
PredictImmune announces commercial partnership with Cambridge Clinical Laboratories
PredictImmune announces commercial partnership with Cambridge Clinical Laboratories (CCL) to promote and supply PredictSURE® IBD, the world’s first...
PredictImmune PROFILE trial recruits over 200 patients
PredictImmune PROFILE trial recruits over 200 patientsThe first biomarker stratified study for Crohn’s disease, funded by Wellcome Trust, reaches...
PredictImmune pleased to announce the appointment of James Clark as Chief Technology Officer
PredictImmune pleased to announce the appointment of James Clark as Chief Technology OfficerCambridge, UK, 14 November 2019: PredictImmune,...
PredictImmune and the Crohn’s & Colitis Foundation announce start of jointly- sponsored study
PredictImmune and the Crohn’s & Colitis Foundation announce start of jointly- sponsored study to validate PredictSURE® IBD, the first prognostic...
PredictImmune appoints Steven S. Martin as non-executive director
PredictImmune appoints Steven S. Martin as non-executive directorManaging Partner of Paxton Advisors, LLC and ex-CEO of Blue Cross and Blue Shield...
PredictImmune announces a strategic agreement with Theradiag for French speaking Europe to commercialise PredictSURE® IBD, the world’s first validated prognostic test for inflammatory bowel disease
PredictImmune announces a strategic agreement with Theradiag for French speaking Europe to commercialise PredictSURE® IBD, the world’s first...
PredictImmune partners with KSL Biomedical to commercialise PredictSURE® IBD prognostic test across North America
PredictImmune announces new strategic partnership to commercialise its PredictSURE® IBD prognostic test for inflammatory bowel disease across North...
Paul Lyons – VP Platform Delivery
Eoin McKinney – CSO
Andy Sandham, Chairman
